Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to Engerix-B 20 Years After Neonatal Vaccination
NCT00774995Phase 4Completed
- Sponsor
- GSK
- Start
- Nov 2008
- Primary completion
- Jun 2010
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started Nov 2008; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00774995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00774995.